NCT01402362

Brief Summary

High risk population: Screening for impaired glucose tolerance.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
550

participants targeted

Target at P75+ for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 24, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 26, 2011

Completed
1 month until next milestone

Study Start

First participant enrolled

September 1, 2011

Completed
Last Updated

July 26, 2011

Status Verified

June 1, 2011

First QC Date

July 24, 2011

Last Update Submit

July 25, 2011

Conditions

Keywords

EthiopiansDiabetes MellitusGlucose toleranceIsraelIncluded in the year 2000 study

Outcome Measures

Primary Outcomes (1)

  • Percent of patients with Diabetes Mellitus or impaired glucose tolerance

    Day 1 of study

Secondary Outcomes (1)

  • Prevalence of hypertension and hyperlipidemia

    Day 1 of study

Study Arms (1)

Ethiopians participating in previous study, year 2000

Eligibility Criteria

Age25 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Ethiopian immigrants to Israel living in Hadera.

You may qualify if:

  • Participation in the year 2000 study
  • Signature of Informed Consent Form

You may not qualify if:

  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Diabetes and Endocrinology Unit, Hillel Yaffe MC, POB169

Hadera, 38100, Israel

Location

MeSH Terms

Conditions

Diabetes MellitusGlucose Intolerance

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesHyperglycemia

Central Study Contacts

Anat Jaffe, MD PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

July 24, 2011

First Posted

July 26, 2011

Study Start

September 1, 2011

Last Updated

July 26, 2011

Record last verified: 2011-06

Locations